Association between urinary 8-hydroxydeoxyguanosine, an indicator of oxidative stress, and the cardio-ankle vascular index in hypertensive patients

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 8, 2012, Pages 747-755

  Masugata, Hisashi ^a   Senda, Shoichi ^a   Murao, Koji ^a   Inukai, Michio ^a   Himoto, Takashi ^a   Hosomi, Naohisa ^b   Okada, Hiroki ^a   Goda, Fuminori ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Arteriosclerosis; Cardio ankle vascular index; Hypertension; Oxidative stress; Urinary 8 OHdG

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIO ANKLE VASCULAR INDEX; CIGARETTE SMOKING; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; IMMUNOAFFINITY CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

EID: 84865705709     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.12716     Document Type: Article

References (31)

1. Griendling KK, FitzGerald GA: Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation, 2003; 108: 1912-1916
2. Mizuno Y, Jacob RF, Mason RP: Inflammation and the development of atherosclerosis. J Atheroscler Thromb, 2011; 18: 351-358
3. Ray T, Maity PC, Banerjee S, Deb S, Dasgupta AK, Sarkar S, Sil AK: Vitamin C prevents cigarette smoke induced atherosclerosis in guinea pig model. J Atheroscler Thromb, 2010; 17: 817-827
4. Iso H: Lifestyle and cardiovascular disease in Japan. J Atheroscler Thromb, 2011; 18: 83-88
5. Walter MF, Jacob RF, Jeffers B, Ghadanfar MM, Preston GM, Buch J, Mason RP; PREVENT study: Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol, 2004; 44: 1996-2002
6. Takaki A, Umemoto S, Ono K, Seki K, Ryoke T, Fujii A, Itagaki T, Harada M, Tanaka M, Yonezawa T, Ogawa H, Matsuzaki M: Add-on therapy of EPA reduces oxidative stress and inhibits the progression of aortic stiffness in patients with coronary artery disease and statin therapy: a randomized controlled study. J Atheroscler Thromb, 2011; 18: 857-866
7. Fukui T, Yamauchi K, Maruyama M, Yasuda T, Kohno M, Abe Y: Significance of measuring oxidative stress in lifestyle-related diseases from the viewpoint of correlation between d-ROMs and BAP in Japanese subjects. Hypertens Res, 2011; 34: 1041-1045
8. Endo K, Miyashita Y, Sasaki H, Ebisuno M, Ohira M, Saiki A, Koide N, Oyama T, Takeyoshi M, Shirai K: Probucol and atorvastatin decrease urinary 8-hydroxy-2'-deoxyguanosine in patients with diabetes and hypercholesterolemia. J Atheroscler Thromb, 2006; 13: 68-75
9. Miyashita Y, Endo K, Saiki A, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohira M, Oyama T, Shirai K: Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients. J Atheroscler Thromb, 2009; 16: 539-545
10. Abe M, Maruyama N, Okada K, Matsumoto S, Matsumoto K, Soma M: Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy. J Atheroscler Thromb, 2011; 18: 1018-1028
11. Yao QH, Mei SR, Weng QF, Zhang PD, Yang Q, Wu CY, Xu GW: Determination of urinary oxidative DNA damage marker 8-hydroxy-2'-deoxyguanosine and the association with cigarette smoking. Talanta, 2004; 63: 617-623
12. Loft S, Vistisen K, Ewertz M, Tjønneland A, Overvad K, Poulsen HE: Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis, 1992; 13: 2241-2247
13. Nishikawa T, Sasahara T, Kiritoshi S, Sonoda K, Senokuchi T, Matsuo T, Kukidome D, Wake N, Matsumura T, Miyamura N, Sakakida M, Kishikawa H, Araki E: Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care, 2003; 26: 1507-1512
14. Miyashita Y, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohira M, Oyama T, Shirai K: Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension. J Atheroscler Thromb, 2009; 16: 621-626
15. Ono H, Minatoguchi S, Watanabe K, Yamada Y, Mizukusa T, Kawasaki H, Takahashi H, Uno T, Tsukamoto T, Hiei K, Fujiwara H: Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension. Hypertens Res, 2008; 31: 271-279
16. Shirai K, Utino J, Otsuka K, Takata M: A novel blood pressure-independent arterial wall stiffness parameter; Cardio Ankle Vascular Index (CAVI). J Atheroscler Thromb, 2006; 13: 101-107
17. Ibata J, Sasaki H, Kakimoto T, Matsuno S, Nakatani M, Kobayashi M, Tatsumi K, Nakano Y, Wakasaki H, Furuta H, Nishi M, Nanjo K: Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabetes Res Clin Pract, 2008; 80: 265-270
18. Okura T, Watanabe S, Kurata M, Manabe S, Koresawa M, Irita J, Enomoto D, Miyoshi K, Fukuoka T, Higaki J: Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res, 2007; 30: 335-340
19. Nakamura K, Tomaru T, Yamamura S, Miyashita Y, Shirai K, Noike H: Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J, 2008; 72: 598-604
20. Nakamura K, Iizuka T, Takahashi M, Shimizu K, Mikamo H, Nakagami T, Suzuki M, Hirano K, Sugiyama Y, Tomaru T, Miyashita Y, Shirai K, Noike H: Association between cardio-ankle vascular index and serum cystatin C levels in patients with cardiovascular risk factor. J Atheroscler Thromb, 2009; 16: 371-379
21. Wu LL, Chiou CC, Chang PY, Wu JT: Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta, 2004; 339: 1-9
22. Soini Y, Haapasaari KM, Vaarala MH, Turpeenniemi-Hujanen T, Kärjä V, Karihtala P: 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma. Int J Clin Exp Pathol, 2011; 4: 267-275
23. Namekata T, Suzuki K, Ishizuka N, Shirai K. Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study. BMC Cardiovasc Disord, 2011; 11: 51
24. Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, Miyashita Y, Saiki A, Takahashi M, Suzuki K, Takata M: Cardio-Ankle Vascular Index (CAVI) as a Novel Indi-cator of Arterial Stiffness: Theory, Evidence and Perspectives. J Atheroscler Thromb, 2011;18: 924-938
25. Kanauchi M, Nishioka H, Hashimoto T: Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron, 2002; 91: 327-329
26. Roselló-Lletí E, de Burgos FG, Morillas P, Cortés R, Martínez-Dolz L, Almenar L, Grigorian L, Orosa P, Portolés M, Bertomeu V, Rivera M: Impact of Cardiovascular Risk Factors and Inflammatory Status on Urinary 8-OHdG in Essential Hypertension. Am J Hypertens, 2012; 25: 236-242
27. Sauvain JJ, Setyan A, Wild P, Tacchini P, Lagger G, Storti F, Deslarzes S, Guillemin M, Rossi MJ, Riediker M: Biomarkers of oxidative stress and its association with the urinary reducing capacity in bus maintenance workers. J Occup Med Toxicol, 2011; 6: 18
28. Abe M, Maruyama N, Okada K, Matsumoto S, Matsumoto K, Soma M: Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria. Hypertens Res, 2011; 34: 935-941
29. Shirai K, Song M, Suzuki J, Kurosu T, Oyama T, Nagayama D, Miyashita Y, Yamamura S, Takahashi M: Contradictory effects of β1-and α1-aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)--CAVI independent of blood pressure. J Atheroscler Thromb, 2011; 18: 49-55
30. Suzuki K, Ito Y, Ochiai J, Aoki K, Wakai K, Tamakoshi A, Ando M, Watanabe Y, Ozasa K, Seki N, Nishino Y, Kondo T, Ohno Y, Tamakoshi A, Mori M, Motohashi Y, Tsuji I, Nakamura Y, Iso H, Mikami H, Hashimoto S, Inaba Y, Hoshiyama Y, Suzuki H, Shimizu H, Toyoshima H, Tokudome S, Ito Y, Kikuchi S, Koizumi A, Kawamura T, Watanabe Y, Miki T, Date C, Sakata K, Nose T, Hayakawa N, Yoshimura T, Fukuda K, Okamoto N, Shio H, Ohno Y, Kitagawa T, Kuroki T, Tajima K; Japan Collaborative Cohort Study Group: The relationship between smoking habits and serum levels of 8-OHdG, oxidized LDL antibodies, Mn-SOD and carotenoids in rural Japanese residents. J Epidemiol, 2003; 13: 29-37
31. Tamae K, Kawai K, Yamasaki S, Kawanami K, Ikeda M, Takahashi K, Miyamoto T, Kato N, Kasai H: Effect of age, smoking and other lifestyle factors on urinary 7-methylguanine and 8-hydroxydeoxyguanosine. Cancer Sci, 2009; 100: 715-721